{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T07:06:53Z","timestamp":1779692813562,"version":"3.53.1"},"reference-count":46,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IDR"],"DOI":"10.2147\/idr.s596309","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T06:55:12Z","timestamp":1779692112000},"page":"1-13","source":"Crossref","is-referenced-by-count":0,"title":["A Fitness Burden Drives the Reversion of in vitro Acquired Doxycycline Resistance in V. cholerae O1"],"prefix":"10.2147","volume":"Volume 19","author":[{"given":"Dayana","family":"Shoukair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9691-7057","authenticated-orcid":true,"given":"Ahmad","family":"Turk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8321-4025","authenticated-orcid":true,"given":"Abdullah","family":"Kurdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4691-8998","authenticated-orcid":true,"given":"Ghassan","family":"Matar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7516-7919","authenticated-orcid":true,"given":"Antoine","family":"Abou Fayad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,5]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/S1473-3099(13)70318-9","volume":"13","author":"Laxminarayan","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nrmicro3270","volume":"12","author":"Andersson","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3390\/antibiotics13010094","volume":"13","author":"Maeda","year":"2024","journal-title":"Antibiotics"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1186920","volume":"14","author":"Vanacker","year":"2023","journal-title":"Front Microbiol"},{"key":"ref5","unstructured":"World Health Organization. Multi-Country Outbreak of Cholera. External Situation Report. 2025;28:\u201324."},{"key":"ref6","unstructured":"World Health Organization. Cholera treatment guidelines. Available from: https:\/\/www.who.int\/. Accessed 2025."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13756-021-00985-w","volume":"10","author":"Ahmadi","year":"2021","journal-title":"Antimicrob Resist Infect Control"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nrmicro3380","volume":"13","author":"Blair","year":"2015","journal-title":"Nat Rev Microbiol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"6963","DOI":"10.1038\/s41467-024-51428-0","volume":"15","author":"Abou Fayad","year":"2024","journal-title":"Nat Commun"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/nrmicro2319","volume":"8","author":"Andersson","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"ref11","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria; Approved Guideline \u2013. Third Edition (M45). Wayne, PA; 2015."},{"key":"ref12","unstructured":"Andrews S. FastQC: a quality control tool for high throughput sequence data. 2010."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"btae066","DOI":"10.1093\/bioinformatics\/btae066","volume":"40","author":"Charron","year":"2024","journal-title":"Bioinformatics"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"ref16","volume-title":"Haplotype-Based Variant Detection From Short-Read Sequencing","year":"2012"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s43588-022-00387-x","volume":"2","author":"Zheng","year":"2022","journal-title":"Nat Comput Sci"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"McLaren","year":"2016","journal-title":"Genome Biol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"giab008","DOI":"10.1093\/gigascience\/giab008","volume":"10","author":"Danecek","year":"2021","journal-title":"Gigascience"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"bpab008","DOI":"10.1093\/biomethods\/bpab008","volume":"6","author":"Hallgren","year":"2021","journal-title":"Biol Methods Protoc"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e96","DOI":"10.1002\/cpbi.96","volume":"69","author":"Yu","year":"2020","journal-title":"Curr Protoc Bioinformatics"},{"key":"ref23","unstructured":"R Core Team. R: a language and environment for statistical computing. (2022)."},{"key":"ref24","unstructured":"McLeod AIK. Kendall rank correlation and Mann\u2013Kendall trend test. 2022."},{"key":"ref25","unstructured":"World Health Organization. Global Task Force on Cholera Control (GTFCC). Interim Technical Note: Use of Antibiotics for the Treatment of Cholera. Available from: https:\/\/www.gtfcc.org\/wp-content\/uploads\/2025\/02\/gtfcc-technical-note-on-use-of-antibiotics-for-the-treatment-of-cholera.pdf. Accessed May 21, 2026."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13756-022-01100-3","volume":"11","author":"Yuan","year":"2022","journal-title":"Antimicrob Resist Infect Control"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.01726","volume":"9","author":"Laviad-Shitrit","year":"2018","journal-title":"Front Microbiol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1038\/s41467-018-04059-1","volume":"9","author":"Wistrand-Yuen","year":"2018","journal-title":"Nat Commun"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"e1002158","DOI":"10.1371\/journal.ppat.1002158","volume":"7","author":"Gullberg","year":"2011","journal-title":"PLOS Pathogens"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"106097","DOI":"10.1016\/j.ijantimicag.2020.106097","volume":"56","author":"Narendrakumar","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1056\/NEJM199708143370701","volume":"337","author":"Sepp\u00e4l\u00e4","year":"1997","journal-title":"N Engl J Med"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"124215","DOI":"10.1016\/j.jhazmat.2020.124215","volume":"405","author":"Wen","year":"2021","journal-title":"J Hazard Mater"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1038\/s41467-024-46571-7","volume":"15","author":"Pal","year":"2024","journal-title":"Nat Commun"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"e47088","DOI":"10.7554\/eLife.47088","volume":"8","author":"Dunai","year":"2019","journal-title":"eLife"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/S0140-6736(00)04519-0","volume":"357","author":"Enne","year":"2001","journal-title":"Lancet"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"100961","DOI":"10.1016\/j.drup.2023.100961","volume":"68","author":"Ma","year":"2023","journal-title":"Drug Resist Updates"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s41579-018-0048-6","volume":"16","author":"Du","year":"2018","journal-title":"Nat Rev Microbiol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3390\/antibiotics11010040","volume":"11","author":"Hasan","year":"2021","journal-title":"Antibiotics"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"e0339824","DOI":"10.1128\/spectrum.03398-24","volume":"13","author":"Xie","year":"2025","journal-title":"Microbiol Spectr"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"e0005671","DOI":"10.1371\/journal.pntd.0005671","volume":"11","author":"Garrine","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1126\/science.aad5901","volume":"358","author":"Weill","year":"2017","journal-title":"Science"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41467-018-08098-6","volume":"10","author":"Nichol","year":"2019","journal-title":"Nat Commun"},{"key":"ref43","volume":"10","author":"Hounmanou","year":"2019","journal-title":"Front Microbiol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3390\/antibiotics12020190","volume":"12","author":"Alkatheri","year":"2023","journal-title":"Antibiotics"},{"key":"ref45","unstructured":"World Health Organization. Cholera, 2023: Global Situation Update and Outbreak Response. (2023). Available from: https:\/\/www.who.int\/publications\/i\/item\/who-cholera-2023-global-situation-update. Accessed May 21, 2026."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"D19","DOI":"10.1093\/nar\/gkq1019","volume":"39","author":"Leinonen","year":"2011","journal-title":"Nucleic Acids Res"}],"container-title":["Infection and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/115576","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/115576","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T06:55:16Z","timestamp":1779692116000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/a-fitness-burden-drives-the-reversion-of-in-vitro-acquired-doxycycline-peer-reviewed-fulltext-article-IDR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":46,"URL":"https:\/\/doi.org\/10.2147\/idr.s596309","relation":{},"ISSN":["1178-6973"],"issn-type":[{"value":"1178-6973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}